If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Two New Senior Appointments

1 Sep 2016 07:00

RNS Number : 6167I
Science in Sport PLC
01 September 2016
 

1 September 2016

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

Two New Senior Appointments to Drive Science in New Product Innovation and Development

Dr. Robert Child is appointed Chief Scientific Officer and Dr James Morton is appointed World Class Knowledge Director

Science in Sport plc (AIM: SIS), a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts, is pleased to announce the appointment of Dr Robert Child as Chief Scientific Officer and Dr James Morton as World Class Knowledge Director, with effect from 1 September 2016.

The joint appointments further bolster SiS' leadership team and its science based credentials as the Company continues with its progressive growth strategy, focused on new product development and international expansion, as well as highlighting that the Company continues to attract the very best experts and talent in the industry.

Dr Robert Child has been appointed as the Group's new Chief Scientific Officer, bringing extensive sports nutrition and biochemical expertise to the management team at Science in Sport. Robert is currently a Performance Biochemist at Team Katusha, a leading World Tour professional cycling team, where he applies performance biochemistry to improve rider health, recovery and performance. Previous to this he was Head of Nutrition for professional cycling teams MTN-Qhubeka, Geox-TMC and Cervelo Test Team; he was also Head of Research at Maximuscle Limited from 2003 to 2011 where he developed a number of innovative, science based supplements, helping establish Maximuscle as a commercially successful brand, before its sale to GlaxoSmithKline. 

In addition to this, Robert has a PhD in Exercise Physiology & Biochemistry and has carried out post-doctoral research at the Department of Medicine, Liverpool University and University College Chichester, specialising in Exercise Physiology, Nutrition & Cellular Signalling, and Exercise Biochemistry & Nutrition. He has also published numerous papers in leading physiology, clinical and sports medicine journals and holds degrees in Sports Science, Adapted Physical Activity and performed research on muscle damage and adaptation to gain a doctorate.

The Company has also appointed Dr James Morton, formerly a scientific advisor to SIS, to the role of World Class Knowledge Director, supporting development of new IP, processes, technologies, capabilities and marketing of SIS products. James is a distinguished sports nutrition consultant with many years' experience. Most recently he has been Head of Performance Nutrition to Team Sky, the leading British World Tour cycling team, contributing to their continued outstanding success. James has worked extensively with professional athletes and sports teams to produce and deliver best in class nutrition plans. He has worked as a nutrition consultant for a number of high-profile sport associations, namely The Football Association, Liverpool Football Club as well as Team Sky.

In addition, James is a Reader in Exercise Metabolism at Liverpool John Moores University where he co-leads one of the world's leading Sport Nutrition Research groups. To date, he has published over 90 research papers and numerous book chapters/books focussing on Sport Nutrition, Sport Physiology and Strength and Conditioning.

Stephen Moon, CEO of Science in Sport, commented: "I am delighted to welcome both Robert and James to our leadership team here at SiS. They both bring a deep scientific experience in sports nutrition and a long track record of working with elite athletes helping to improve their performance and overall health and recovery.

"Our brand's heritage is built on science and innovation, with elite usage and insight underpinning that. Robert's and James' skills will be an undoubted asset as we seek to continue to deliver new innovative products and build our international presence in the global endurance sports nutrition market."

For further information:

Science in Sport PLC

+44 (0) 20 7400 3700

Stephen Moon, CEO

Elizabeth Lake, Finance Director

 

Cenkos Securities - NOMAD and Broker

 

+44 (0) 20 7397 8900

Bobbie Hilliam

Yellow Jersey PR - Financial PR

Felicity Winkles

+44 (0) 7748 843 871

Harriet Jackson

+44 (0) 7544 275 882

Notes for editors

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community.

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars and hydration tablets; SiS REGO, including protein-based recovery powders and bars; and SiS Protein, a whey protein range for lean muscle development including WHEY20, a novel ready to consume whey protein product. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites. The Company sold product in more than 100 countries in 2015.

SiS is the official sports nutrition supplier to professional cycling teams Team Sky, Team WIGGINS and USA Cycling. The company is also the official sports nutrition partner to Liverpool FC and the official supplier of sports drinks and sports nutrition to the GB Rowing Team. In addition, Olympians Sir Chris Hoy MBE and Katarina Johnson-Thompson are brand ambassadors, and Mark Cavendish is an Elite Sports Consultant.

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMMGFRVMNGVZM
Date   Source Headline
20th Jun 20178:00 amRNSPDMR Dealing
15th Jun 20177:00 amRNSSIS to fuel British Triathlon
30th May 20177:00 amRNSSIS granted patent for novel WHEY20
19th May 20175:17 pmRNSPosting of Annual Report
18th May 20177:00 amRNSSIS to Fuel Cycling Australia To Tokyo 2020
12th May 20179:00 amRNSHolding(s) in Company
3rd May 20179:23 amRNSHolding(s) in Company
23rd Mar 20171:00 pmRNSPDMR Dealings and Issue of Equity
23rd Mar 20177:00 amRNSFinal Results
2nd Mar 20179:15 amRNSTotal Voting Rights
19th Jan 20178:44 amRNSHolding(s) in Company
17th Jan 20177:00 amRNSSIS Extends World Class Banned Substance Testing
10th Jan 20177:00 amRNSSIS To Fuel British Cycling To Tokyo 2020
9th Jan 20175:24 pmRNSIssue of Equity
5th Jan 20177:00 amRNSPre-Close Trading Update
29th Nov 20167:00 amRNSSiS receives award from Investors in People
17th Nov 20167:00 amRNSDirector/PDMR Shareholding
16th Nov 20167:00 amRNSDirector/PDMR Shareholding
27th Oct 20167:00 amRNSDirector/PDMR Shareholding
18th Oct 20167:00 amRNSAppointment of US Country Manager
26th Sep 20164:09 pmRNSNew Long Term Incentive Plan
22nd Sep 20167:00 amRNSHalf Yearly Report
21st Sep 20162:45 pmRNSAppointment of Non-Executive Director
1st Sep 20167:00 amRNSTwo New Senior Appointments
30th Aug 20167:00 amRNSOfficial Sports Nutrition Partner to Liverpool FC
25th Aug 20162:04 pmRNSHolding(s) in Company
12th Aug 20163:03 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12th Aug 20163:02 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Aug 20167:00 amRNSOfficial Sports Nutrition Supplier for USA Cycling
21st Jul 20167:00 amRNSHalf Year Trading Update
23rd Jun 20161:03 pmRNSResult of AGM
8th Jun 201610:23 amRNSHolding(s) in Company
3rd Jun 20169:57 amRNSHolding(s) in Company
1st Jun 20164:54 pmRNSHolding(s) in Company
23rd May 20167:00 amRNSAnnual Report and Notice of AGM
6th May 20167:00 amRNSDirectorate Change
8th Apr 20164:20 pmRNSHolding(s) in Company
23rd Mar 20165:24 pmRNSIssue of Equity
22nd Mar 20165:08 pmRNSGrant of options
22nd Mar 20167:00 amRNSFinal Results
20th Jan 20167:00 amRNSTrading Statement
4th Jan 20162:25 pmRNSIssue of Equity
22nd Dec 20153:19 pmRNSHolding(s) in Company
19th Nov 201511:33 amRNSHolding(s) in Company
17th Nov 20154:00 pmRNSHolding(s) in Company
17th Nov 20154:00 pmRNSHolding(s) in Company
17th Nov 20154:00 pmRNSHolding(s) in Company
17th Nov 20159:05 amRNSHolding(s) in Company
16th Nov 201511:07 amRNSHolding(s) in Company
16th Nov 20157:00 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.